SCICLONE REPORTS ZADAXIN POSITIVE DATA FOR HEPATITIS PATIENTS.:

It is not intended to be a substitute for face to face medical advice from a qualified healthcare professional. These pages are only provided for the purpose of opening community discussions about that drug by our users. Our website displays many pages which do not contain any medical information regarding the drug name stated.

Thymosin alpha 1 is an acetylated polypeptide with the following sequence: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH,and. After reconstitution, the final concentration of ZADAXIN (thymalfasin) is 1. alpha 1 identical to human thymosin alpha 1. thymosin alpha 1 (thymalfasin) for subcutaneous injection is. a purified sterile lyophilized preparation of chemically synthesized thymosin.

I just recently just heard about a drug called Zadaxin/thymosin alpha 1 and wondered if anyone here has tried it. Its mentioned on this website as a treatment for ME/CFS and thought it sounded very interesting. I contacted 2 pharmaceutical companies a few weeks ago - one in Hong Kong and the other one in India both of whom manufacture Thymosin. The one in India never got back to me after I emailed them twice and the HK one said that they couldnt export it to the UK as a pharmaceutical - they can only sell it as a "sample for research".

The primary drug at SCLN is ZADAXIN and the treatment given with the Novartis H1N1 vaccine led to statistically significant increases in the percentage of subjects who seroconverted when evaluated at both 21 days and 42 days after vaccination, as... ZADAXIN is also used for the treatment of hepatitis B and hepatitis C viruses, and certain cancers, as well as for use as a vaccine adjuvant or as a chemotherapy adjuvant for cancer patients with weakened immune systems. "We are pleased by the results of this study which demonstrate that ZADAXIN provides a significant and rapid enhancement benefit to the H1N1 vaccine during the critical first six weeks following vaccination," said Israel Rios, MD, SCLN’s Sr. VP... Nearly $2 off its high, SCLN is also a short-term ‘ Buy ’ consideration for me. SCLN will report its Q2 ’10 numbers on Monday, August 9, 2010. 5 cents per common share and announced a share repurchase program authorizing up to $35 million in share repurchases. ZADAXIN has approval in approximately 30 countries, primarily in Asia, eastern Europe, the Middle East, and Latin America. 33 set on 09-01-09 with current trailing twelve month revenues of $75+ million and a positive, corresponding diluted EPS of +$0. First up this morning we have S&P SmallCap 600 company EPIQ Systems Inc . , ( EPIQ ) http://www. 05 set on 10-14-09 with current trailing twelve month revenues of $528+ million and a positive, corresponding diluted EPS of +$0. 55 set on 07-30-09 with current trailing twelve month revenues of $233+ million and a positive, corresponding diluted EPS of +$0. 50 off its high, EPIQ is a short-term ‘ Buy ’ consideration for me.  . Next up we have SciClone Pharmaceuticals Inc. 91 range on a 3-Month average daily trading volume of 224,670 shares.